HOUT-13. CLINICAL TRIALS IN GLIOBLASTOMA: LEARNING FROM PREVIOUS EXPERIENCES TOWARDS OPTIMAL DEVELOPMENT OF TRIAL DESIGN

INTRODUCTION: We undertook a literature review testing the hypothesis that inefficiencies in the Phase 2/3 transition contributes to most GBM Phase 3 trials (P3T’s) being negative. METHODS: Studies between 2005–2019 inclusive were identified though MEDLINE(R) using keywords and MeSH terms, and manua...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Balasubramanian, Adithya, Gunjur, Ashray, Parakh, Sagun, Cher, Lawrence, Gan, Hui
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Health Outcome Measures
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847581/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.478
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi